Apurinic-Apyrimidinic Endonuclease
From Proteopedia
(Difference between revisions)
| Line 34: | Line 34: | ||
* [http://www.rcsb.org/pdb/explore/explore.do?structureId=1DE8 APE1 (1de8) RCSB PDB page] | * [http://www.rcsb.org/pdb/explore/explore.do?structureId=1DE8 APE1 (1de8) RCSB PDB page] | ||
* [http://www.brenda-enzymes.org/php/result_flat.php4?ecno=4.2.99.18 BRENDA-The comprehensive enzyme information system-APE1 page] | * [http://www.brenda-enzymes.org/php/result_flat.php4?ecno=4.2.99.18 BRENDA-The comprehensive enzyme information system-APE1 page] | ||
| + | |||
| + | ==3D structures of Apurinic/Apyrimidinic Endonuclease== | ||
| + | [[AApurinic/apyrimidinic endonuclease 3D structures]] | ||
| + | |||
</StructureSection> | </StructureSection> | ||
| Line 51: | Line 55: | ||
**[[2o3h]] – hAPE1 (mutant) + Sm<br /> | **[[2o3h]] – hAPE1 (mutant) + Sm<br /> | ||
**[[4qhd]] – hAPE1 (mutant) <br /> | **[[4qhd]] – hAPE1 (mutant) <br /> | ||
| - | **[[1de8]], [[1de9]], [[1dew]], [[5wn0]], [[5wn1]], [[5wn2]], [[5wn3]], [[5wn4]], [[5wn5]] – hAPE1 + DNA<br /> | + | **[[6mk3]], [[6mkm]] – hAPE1 + DMSO<br /> |
| + | **[[6mkk]] – hAPE1 + DMSO + Mg<br /> | ||
| + | **[[6mko]] – hAPE1 + glycerol<br /> | ||
| + | **[[1de8]], [[1de9]], [[1dew]], [[5wn0]], [[5wn1]], [[5wn2]], [[5wn3]], [[5wn4]], [[5wn5]], [[6boq]], [[6bor]], [[6bos]] – hAPE1 + DNA<br /> | ||
| + | **[[6bot]], [[6bou]], [[6bov]], [[6bow]] – hAPE1 (mutant) + DNA<br /> | ||
**[[5dff]], [[5dfh]], [[5dfi]], [[5dfj]], [[5dg0]], [[4iem]] – hAPE1 + DNA + Mg<br /> | **[[5dff]], [[5dfh]], [[5dfi]], [[5dfj]], [[5dg0]], [[4iem]] – hAPE1 + DNA + Mg<br /> | ||
**[[2j63]] – APE – ''Leishmania major''<br /> | **[[2j63]] – APE – ''Leishmania major''<br /> | ||
**[[2jc5]] - APE+ Mg – ''Neisseria meningitidis'' | **[[2jc5]] - APE+ Mg – ''Neisseria meningitidis'' | ||
| - | *Aprataxin and PNK-like factor (APLF) apurinic/apyrimidinic endonuclease-1 | + | *Aprataxin and PNK-like factor (APLF) apurinic/apyrimidinic endonuclease-1; domains – FHA 1-105; PBZ-type 363-451 |
**[[2kqb]], [[2kqc]] – hAPLF PBZ-type domain + Zn<br /> | **[[2kqb]], [[2kqc]] – hAPLF PBZ-type domain + Zn<br /> | ||
**[[2kqd]], [[2kqe]] - hAPLF PBZ-type domain + ribofuranosyladenosine + Zn<br /> | **[[2kqd]], [[2kqe]] - hAPLF PBZ-type domain + ribofuranosyladenosine + Zn<br /> | ||
| - | **[[2kuo]] – hAPLF | + | **[[2kuo]] – hAPLF PBZ-type domain – NMR<br /> |
| - | **[[5e50]] – hAPLF | + | **[[5w7w]] - hAPLF FHA domain<br /> |
| + | **[[5w7x]], [[5w7y]] – hAPLF FHA domain + XRCC1 peptide<br /> | ||
| + | **[[5e50]] – hAPLF FHA domain + XRCC4 peptide<br /> | ||
}} | }} | ||
Revision as of 10:35, 19 March 2019
| |||||||||||
3D structures of Apurinic/Apyrimidinic Endonuclease
Updated on 19-March-2019
References
- ↑ 1.0 1.1 1.2 1.3 1.4 1.5 1.6 1.7 1.8 Masood, Z.H. 2000. Functional characterization of APE1 varients identified in the human population. Nucleic Acid Research 28: 3871-3879
- ↑ 2.0 2.1 Barnes, T., et al. 2009. Identification of Apurinic/apyrimidinic endoribonuclease 1 (APE1) as the endoribonuclease that cleaves c-myc mRNA in vitro. Nucleic Acid Research 37: 3946-3958
- ↑ 3.0 3.1 3.2 Ando, K. et al. 2008. A new APE1/Ref-1-dependent pathway leading to reduction of NF-kB and AP-1, and activation of their DNA binding activity. Nucleic Acid research 36(13): 4327-4336.
- ↑ 4.0 4.1 4.2 4.3 4.4 4.5 4.6 4.7 4.8 4.9 Mol,C.D. et al. 2000. DNA-bound structures and mutants reveal abasic DNA binding by APE1 DNA repair and coordination. Nature 403:451-456.
Proteopedia Page Contributors and Editors (what is this?)
Mark Barnes, Michal Harel, Alexander Berchansky, David Canner, Jaime Prilusky, Andrea Gorrell, Eran Hodis, Joel L. Sussman
